GDMT in Heart Failure – The Power of Pills: Opportunities and Challenges (Michelle Kittleson, MD)

The talk will cover optimal guideline-directed medical therapy in heart failure with reduced
ejection fraction, the pitfalls in clinical trial interpretation, and practical tips for implementation.

Objectives:

1. Identify optimal guideline-directed medical therapy for heart failure with reduced ejection fraction
2. Describe pitfalls to clinical trials of GDMT in HF
3. Determine a strategy for the implementation of GDMT

** This medical education program may contain graphic content. **
_________________________________

A DeBakey CV Education event

Presented by Houston Methodist DeBakey Heart & Vascular Center.

Building on Dr. Michael E. DeBakey’s commitment to excellence in education, Houston Methodist DeBakey CV Education is an epicenter for cardiovascular academic and clinical educational programs that support the provision of optimal care to patients suffering from cardiovascular conditions and diseases.

FOR MORE INFORMATION
DeBakey CV Education:

Follow Us:

Want concise, relevant reviews of the hottest topics in CV medicine? Subscribe for FREE to the Methodist DeBakey Cardiovascular Journal for quarterly, peer-reviewed issues delivered to your door.

[sunving]

thank you Dr Kittleson, wonderful lecture, i can remember only take home message

[adriannunez]

THANK you for addressing the nuances around the indication for isosorbide din/hydralazine for Black Americans. Best explanation I've heard to date

[kingsleyihe]

Nice of mastering the art of patient care